Heart transplant survivor fights to keep access to anti-rejection drug
At 11, Payton Herres received a donated heart after years of health problems caused by Ebstein’s anomaly. Fifteen years later, she faced a fight to access everolimus, the anti-rejection medicine she had relied on since 2013. After her insurer stopped covering the drug and its cost rose sharply, Herres turned to social media. Her story

